- Home
- BMNR vs IMAB Comparison
BMNR vs IMAB Comparison
Compare BMNR & IMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMNR
- IMAB
- Stock Information
- Founded
- BMNR 2019
- IMAB 2014
- Country
- BMNR United States
- IMAB United States
- Employees
- BMNR N/A
- IMAB N/A
- Industry
- BMNR
- IMAB Biotechnology: Pharmaceutical Preparations
- Sector
- BMNR
- IMAB Health Care
- Exchange
- BMNR NYSE
- IMAB Nasdaq
- Market Cap
- BMNR 205.5M
- IMAB 200.9M
- IPO Year
- BMNR N/A
- IMAB 2020
- Fundamental
- Price
- BMNR $39.72
- IMAB $2.11
- Analyst Decision
- BMNR
- IMAB Strong Buy
- Analyst Count
- BMNR 0
- IMAB 3
- Target Price
- BMNR N/A
- IMAB $6.33
- AVG Volume (30 Days)
- BMNR 30.2M
- IMAB 392.1K
- Earning Date
- BMNR 07-11-2025
- IMAB 05-15-2025
- Dividend Yield
- BMNR N/A
- IMAB N/A
- EPS Growth
- BMNR N/A
- IMAB N/A
- EPS
- BMNR N/A
- IMAB N/A
- Revenue
- BMNR $5,452,545.00
- IMAB N/A
- Revenue This Year
- BMNR N/A
- IMAB N/A
- Revenue Next Year
- BMNR N/A
- IMAB N/A
- P/E Ratio
- BMNR N/A
- IMAB N/A
- Revenue Growth
- BMNR 89.77
- IMAB N/A
- 52 Week Low
- BMNR $3.92
- IMAB $0.60
- 52 Week High
- BMNR $161.00
- IMAB $3.08
- Technical
- Relative Strength Index (RSI)
- BMNR N/A
- IMAB 49.47
- Support Level
- BMNR N/A
- IMAB $2.01
- Resistance Level
- BMNR N/A
- IMAB $2.25
- Average True Range (ATR)
- BMNR 0.00
- IMAB 0.13
- MACD
- BMNR 0.00
- IMAB -0.03
- Stochastic Oscillator
- BMNR 0.00
- IMAB 25.00
About BMNR BITMINE IMMERSION TECNOLOGIES INC
BitMine Immersion Technologies Inc is a blockchain technology company that is building out industrial-scale digital asset mining, equipment sales, and hosting operations. The company's primary business is data center focused, both mining Bitcoin for its account as well as hosting third-party Bitcoin mining servers. The Company's primary business is self-mining bitcoin for its own account, as well as hosting third-party equipment used in mining of digital asset coins and tokens, specifically bitcoin. Company's state of the art facilities will be specifically designed and constructed for housing mining equipment. The data centers will provide power, racks, proprietary thermodynamic management.
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).